FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

4935711000001104: Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26955901000001113 Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26956001000001116 Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Is a Oxymetazoline 0.05% nasal spray 15 ml true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Is pack of Afrazine 0.05% nasal spray (Schering-Plough Ltd) false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has active ingredient Oxymetazoline hydrochloride false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has active ingredient Oxymetazoline false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has excipient Benzalkonium chloride false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Legal category General sales list true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has AMP Afrazine 0.05% nasal spray (Schering-Plough Ltd) true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has specific active ingredient Oxymetazoline hydrochloride true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Afrazine 0.05% nasal spray (Schering-Plough Ltd) 15 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start